FDA Inspection 1208871 - Bristol-Myers Squibb Company - June 16, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Bristol-Myers Squibb Company

Record Details

This FDA Inspection record concerns Bristol-Myers Squibb Company, with an inspection on June 16, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: Bristol-Myers Squibb Company
Inspection Date: June 16, 2023
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · ad863020-b34a-40d2-91ba-237fdca75cc3

Violation Codes4

21 CFR 211.100(a)21 CFR 211.137(a)21 CFR 211.42(c)(10)(iv)21 CFR 211.42(c)(5)

Full citation text and observation details available on the Dashboard.